Skip to content

Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome

Effect of Transfer Energy Capacitive and Resistive on Carpal Tunnel Syndrome Post Burn

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07660328
Enrollment
52
Registered
2026-06-22
Start date
2026-06-16
Completion date
2026-12-01
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome (CTS) Post-burn

Keywords

carpal tunnel syndrome post-burn, TECAR, Hand grip, BOSTON questionnaire, VAS

Brief summary

Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy that can develop as a secondary complication following deep burns involving the hand or wrist. Post-burn CTS arises due to factors such as fibrosis, edema, and scar contracture, which may increase pressure on the median nerve within the carpal tunnel, leading to significant pain, sensory disturbances, and impaired hand function Recent studies support the effectiveness of Transfer Energy Capacitive and Resistive (TECAR ) therapy in idiopathic CTS, showing improvements in pain, symptom severity, and function, as measured by validated tools such as the Boston Carpal Tunnel Questionnaire (BCTQ) and Visual Analogue Scale (VAS). A study reported that both TECAR and ultrasound groups showed significant symptom improvement after treatment, although ultrasound had more sustained effects on median nerve cross-sectional area at 3 months

Detailed description

This study will involve 52 patients diagnosed with CTS post-burn; they will receive TECAR as an intervention. The outcome measures include ( VAS, Arabic version of Boston Carpal Tunnel Questionnaire, and Camry Digital Handgrip Dynamometer

Interventions

DEVICETransfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }

TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), The passive electrode was fixed to the dorsum of the hand while the active electrode was moved in a circular manner from the proximal carpal tunnel to the median nerve pathway of the palm in three sessions per week for two weeks

OTHERStandard Hand Rehabilitation [ US }

US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Participant is between 20 and 40 years of age. * Diagnosed with mild to moderate carpal tunnel syndrome (CTS). * History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%. * Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome. * Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test. * Participant provides written informed consent before enrollment.

Exclusion criteria

* History of double crush syndrome, cervical radiculopathy, or fibromyalgia. * History of wrist fracture or distal radius fracture. * Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA). * Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases. * Current or past history of cancer. * Use of a hand or wrist splint within the past three months. * Presence of an implanted pacemaker or electrical prosthesis.

Design outcomes

Primary

MeasureTime frameDescription
Symptom SeverityBaseline and 2 weeksThe Arabic version of the BCTQ-SSS will be used to self-report symptom severity. It consists of 11 items assessing pain, numbness, paresthesia, weakness, and nocturnal symptoms. Each item is scored from 1 (never/none) to 5 (most severe). The overall score is calculated as the mean of the items, ranging from 1 to 5, where higher scores indicate worse symptom severity.
Functional StatusBaseline and 2 weeks.The Arabic version of the BCTQ-FSS will be used to evaluate hand function across 8 common activities. Each activity is scored from 1 (no difficulty) to 5 (cannot perform the activity at all). The total score is the mean of the items, ranging from 1 to 5, where higher scores represent greater functional impairment.
Grip StrengthBaseline and 2 weeks.Objective hand function and force production of the median nerve-innervated muscles will be measured using a Camry Digital Handgrip Dynamometer. Measurements are recorded in kilograms (kg), up to a maximum strength of 90 kg. Higher scores indicate greater hand grip strength.

Secondary

MeasureTime frameDescription
Pain IntensityBaseline and 2 weeks.Pain intensity will be measured using the Arabic version of the VAS, where patients mark their current pain level on a 10-cm line. The scale ranges from 0 cm ("no pain") to 10 cm ("worst pain"). Higher scores represent greater pain severity.

Countries

Egypt

Contacts

CONTACTAhmed abdelnasr Mohamed Youness, Demonstrator (TA)
pt.ahmed.mido@gmail.com+2001553712231
CONTACTNada Mohamed Yousef, Lecturer
Dr.nada123.ny@gmail.com+2001002010168
STUDY_DIRECTORWafaa Hussien Borhan, Professor

Cairo University

STUDY_DIRECTORAshraf Alsibai Mohamed, Professor

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026